CVS Health Corporation (CVS)
CVS Health Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
CVS Health Corporation (CVS) is a Medical - Healthcare Plans company based in US with a market capitalization of $141.1B. Revenue grew 7.8% year-over-year and the company generated $7.8B in free cash flow. This page tracks CVS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 300K employees · IPO Nov 20, 1996
Valuation
Valuation & price
$95.89as of May 17, 2026· -8.5% vs 52w high
68.9
P/E ratio
Latest-FY diluted EPS
1.88
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$141.1B
Market cap
7.8%
Revenue growth (YoY)
13.8%
Gross margin
$7.8B
Free cash flow (USD)
$82.9B
Net debt
0.6%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
2
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 6, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- FinancingMay 22, 2026Filing
Securities Registration
- Insider sellMay 21, 2026Filing
Insider Sell $317.5MROBBINS LARRY · Director · $317.5M
- 8-K eventMay 18, 2026Filing
Annual Meeting Results
- Insider sellMay 11, 2026Filing
Insider Sell $6.2MMandadi Tilak · EVP, Chief Exp & Tech Officer · $6.2M
- 8-K eventMay 6, 2026Filing
Earnings Release
- Quarterly reportMay 6, 2026Filing
10-Q Filed
Questions
Frequently asked questions
What is CVS Health Corporation's market cap?
CVS Health Corporation (CVS) has a market capitalization of $141.1B.
What is CVS's P/E ratio?
CVS trades at a price-to-earnings ratio of 68.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is CVS's price-to-book (P/B) ratio?
CVS trades at 1.88 times book value per share.
Are insiders buying CVS stock?
SEC Form 4 filings show no open-market insider buys at CVS Health Corporation in the last 90 days (2 sells).
Same arena
Related companies in Medical - Healthcare Plans
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.